Author

Vamsidhar Velcheti

NYU Langone HealthORCID 0000-0002-6589-0759Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Vamsidhar Velcheti1 paper · Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clinic Jacksonville, FL, USA;

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:gene regulatory network inference· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Aaron Timothy GriffiniD· 1 shared Adriana HeguyiD· 1 shared Alice Tsang ShawiD· 1 shared Andre Luis MoreiraiD· 1 shared Andrea CalifanoiD· 1 shared Andrew T. ChowiD· 1 shared Anna H. YeatoniD· 1 shared Aristotelis TsirigosiD· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aaron Timothy GriffinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsNature CommunicationsPeer-reviewedNov 8, 2023

Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

Igor Dolgalev, Hua Zhou, Nina Murrell…·Aristotelis Tsirigos

This study identifies inflammation in tumor-adjacent lung tissue as a predictor of clinical outcome in lung adenocarcinoma using multi-omic analysis of 143 stage I cases.

37 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintMar 21, 2022

Integrative Analysis of Checkpoint Blockade Response in Advanced Non-Small Cell Lung Cancer

Arvind Ravi, Justin F. Gainor, Monica B. Arniella…·Matthew David Hellmann

This study identifies molecular and immune features associated with response to anti-PD-(L)1 therapy in NSCLC using a cohort of 393 patients.

1 citation

humanwhole-exome sequencing

𝕏 PostBluesky